Today

Agents

Chat

Arena

Discover

More

App

Immunome, Inc.: Leerink Partners raises target price to $35 from $33

IMNM•2026-10-22

Leerink Partners raised its target price for Immunome to $35 from $33.

Related News

A

FDA lifts clinical hold on Arbutus Biopharma's AB-101

ABUS•2026-10-22

Oil jumps on escalating Middle East conflict

USO•2026-10-22

Crown Castle target price raised to $98 from $92 by TD Cowen

CCI•2026-10-22

BlackRock cuts total voting rights in Evonik to 5.09% from 5.11%

BLK•2026-10-22

Centrus Energy Corp.: Truist Securities cuts target price to $178 from $215

LEU•2026-10-22

Immunome, Inc.: Leerink Partners raises target price to $35 from $33 - IMNM News | Rallies